Skip to main content
ARS Home » Midwest Area » Ames, Iowa » National Animal Disease Center » Infectious Bacterial Diseases Research » Research » Publications at this Location » Publication #211685

Title: Biomarkers of CD4+ CTL cell Mediated Immunity to Tuberculosis

Author
item ENDSLEY, JANICE - UNIV. OF TX MED. BR.
item HOGG, ALISON - INST. FOR AN. HEALTH, UK
item SHELL, LIS - UNIV. OF TX MED. BR.
item MCALAUY, MARTIN - INST. FOR AN. HEALTH, UK
item SCHERER, CHARLES - UNIV. OF TX MED. BR.
item COFFEY, TRACEY - INST. FOR AN. HEALTH, UK
item HOWARD, CHRIS - INST. FOR AN. HEALTH, UK
item Nonnecke, Brian
item Waters, Wade
item ESTES, D - UNIV. OF TX MED. BR.

Submitted to: Meeting Abstract
Publication Type: Abstract Only
Publication Acceptance Date: 5/18/2007
Publication Date: 5/18/2007
Citation: Endsley, J.J., Hogg, A., Shell, L., Mcalauy, M., Scherer, C.C., Coffey, T., Howard, C., Nonnecke, B.J., Waters, W.R., Estes, D.M. 2007. Biomarkers of CD4+ CTL cell Mediated Immunity to Tuberculosis [abstract]. American Association of Imunologists. p. 43.49.

Interpretive Summary:

Technical Abstract: The immune responses mediated by interactions between T-lymphocyte subsets and mycobacteria-infected macrophages are critical for control of tuberculosis. In these studies, the bovine model was used to characterize the cytolytic and mycobactericidal CD4+ T cell response induced by BCG vaccination. Antigenic stimulation of CD4+ T-cells from BCG vaccinated cattle induced expression of perforin and IFNgamma in cells expressing a CD45RA-, CD45RO+, and CD62L+ cell surface phenotype. Antigen specific enhancement of granulysin, IFNgamma, perforin, IL-4, IL-13, and IL-21 mRNA expression was detected and not detected for IL-2, IL-6, IL-10, IL-15, TNF {alpha}, FasL, and CD40L. Following antigenic stimulation, CD4+ T cells from BCG vaccinated animals contributed to reduction of intracellular BCG in infected macrophages. These results demonstrate that vaccination with BCG induces a subpopulation of mycobacteria-specific CD4+ T cells that are characterized by the expression of a cell-surface memory phenotype, enhanced expression of mycobactericidal molecules, and anti-mycobacterial activity against intracellular M. bovis. This work was supported by the NIAID Fellowship for Training in Emerging and Re-emerging Infectious Disease and the Sealy Center for Vaccine Development, UTMB, the Texas-United Kingdom Collaborative Research Initiative, and the Institute for Animal Health by DEFRA and the BBSRC, UK.